TCL Archive Guest Editorial : Why I Don’t Want to Pay for Your Horoscope: Reflections on FDA Warning to 23 and Me December 13, 2013
TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013
TCL Archive American Association for Cancer Research Presents Awards at 2012 Annual Meeting April 6, 2012
